JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 27, 2004; DOI: 10.1124/jpet.104.069930


0022-3565/04/3111-14-21$20.00
JPET 311:14-21, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.069930v1
311/1/14    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raines, D. E.
Right arrow Articles by Stevens, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raines, D. E.
Right arrow Articles by Stevens, R. J.

NEUROPHARMACOLOGY

The N-Methyl-D-aspartate Receptor Inhibitory Potencies of Aromatic Inhaled Drugs of Abuse: Evidence for Modulation by Cation-{pi} Interactions

Douglas E. Raines, Fredrick Gioia, Robert J. Claycomb, and Renna J. Stevens

Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, Massachusetts

Benzene and several close structural analogs are inhaled drugs of abuse with general anesthetic activity. By virtue of their {pi} electron clouds, they may engage in attractive electrostatic interactions with cationic atomic charges on protein targets. In this study, we tested the hypothesis that inhaled drugs of abuse inhibit human N-methyl-D-aspartate (NMDA) receptors with potencies that correlate with their abilities to engage in cation-{pi} interactions. Electrophysiological techniques were used to define the NR1/NR2B NMDA receptor inhibitory concentrations of volatile benzene analogs, and computer modeling was used to quantify their abilities to engage in cation-{pi} interactions and their molecular volumes. In addition, each compound's octanol/gas partition coefficient (a measure of hydrophobicity) was quantified. All 18 compounds inhibited human NR1/NR2B NMDA receptors reversibly and in a concentration-dependent manner. NMDA receptor inhibitory potency correlated strongly with the ability to engage in cation-{pi} interactions, weakly with hydrophobicity, and was independent of molecular volume. This is consistent with the hypothesis that cation-{pi} interactions enhance the binding of inhaled drugs of abuse to the NMDA receptor and suggests that the receptor binding site(s) for these drugs possesses significant cationic character.


Received April 13, 2004; accepted May 27, 2004.

Address correspondence to: Dr. Douglas E. Raines, Department of Anesthesia and Critical Care, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114. E-mail: draines{at}partners.org




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. C. Sewell, D. E. Raines, E. I. Eger II, M. J. Laster, and J. W. Sear
A Comparison of the Molecular Bases for N-Methyl-d-Aspartate-Receptor Inhibition Versus Immobilizing Activities of Volatile Aromatic Anesthetics
Anesth. Analg., January 1, 2009; 108(1): 168 - 175.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Horishita, E. I. Eger II, and R. A. Harris
The Effects of Volatile Aromatic Anesthetics on Voltage-Gated Na+ Channels Expressed in Xenopus Oocytes
Anesth. Analg., November 1, 2008; 107(5): 1579 - 1586.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. M. Sonner
A Hypothesis on the Origin and Evolution of the Response to Inhaled Anesthetics
Anesth. Analg., September 1, 2008; 107(3): 849 - 854.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. I. Eger II, M. Tang, M. Liao, M. J. Laster, K. Solt, P. Flood, A. Jenkins, D. Raines, J. F. Hendrickx, S. L. Shafer, et al.
Inhaled Anesthetics Do Not Combine to Produce Synergistic Effects Regarding Minimum Alveolar Anesthetic Concentration in Rats
Anesth. Analg., August 1, 2008; 107(2): 479 - 485.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. W. Kelly, K. Solt, and D. E. Raines
Volatile Aromatic Anesthetics Variably Impact Human {gamma}-Aminobutyric Acid Type A Receptor Function
Anesth. Analg., November 1, 2007; 105(5): 1287 - 1292.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Ogata, M. Shiraishi, T. Namba, C. T. Smothers, J. J. Woodward, and R. A. Harris
Effects of Anesthetics on Mutant N-Methyl-D-Aspartate Receptors Expressed in Xenopus Oocytes
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 434 - 443.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. Brosnan, D. Gong, J. Cotten, B. Keshavaprasad, C. S. Yost, E. I. Eger II, and J. M. Sonner
Chirality in Anesthesia II: Stereoselective Modulation of Ion Channel Function by Secondary Alcohol Enantiomers.
Anesth. Analg., July 1, 2006; 103(1): 86 - 91.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. Solt, E. I. Eger II, and D. E. Raines
Differential Modulation of Human N-Methyl-d-Aspartate Receptors by Structurally Diverse General Anesthetics.
Anesth. Analg., May 1, 2006; 102(5): 1407 - 1411.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.